Evidence-Based Hair


 

Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)

0 views
April 7, 2023
Comments 0
Login to view comments. Click here to Login